Key terms
About CMPS
Compass Pathways Plc is an investment holding company. It operates through its subsidiaries which provide mental health care services. The company was founded by Goldsmith George Jay and Malievaskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest CMPS news
Apr 11
10:24am ET
Here’s What You Missed in Cannabis, Psychedelics This Week
Apr 04
11:06am ET
Here’s What You Missed in Cannabis, Psychedelics This Week
Apr 01
7:21am ET
Analysts’ Top Healthcare Picks: Wave Life Sciences (WVE), Passage Bio (PASG)
Apr 01
4:24am ET
Compass Pathways initiated with an Overweight at Morgan Stanley
Apr 01
4:17am ET
Buy Rating on COMPASS Pathways: COMP360’s Market Potential and Promising TRD Therapy
Mar 28
11:32am ET
Rising High: Exclusive talk with financial services firm Safe Harbor Financial
Mar 28
8:12am ET
COMPASS Pathways Leadership Restructure and Board Reshuffle
Mar 28
8:12am ET
Compass Pathways co-founders depart from board, David Norton named interim chair
Mar 21
10:52am ET
Here’s What You Missed in Cannabis, Psychedelics This Week
Mar 20
5:07am ET
Analysts’ Top Healthcare Picks: Prime Medicine, Inc. (PRME), Alcidion Group Limited (AU:ALC)
Mar 19
12:15am ET
Buy Rating Affirmed for COMPASS Pathways Amid Promising Neuropsychiatric Treatment Advances
Mar 14
11:15am ET
Rising High: Exclusive talk with cannabis market research firm BDSA
Mar 07
1:09pm ET
Rising High: Exclusive talk with multi-state operator C3 Industries
Mar 07
10:46am ET
Rising High: Exclusive talk with vape tech developer Ispire Technology
Mar 05
12:35pm ET
COMPASS Pathways: A Buy Recommendation Anchored by Strong Cash Reserves and Strategic Collaborations
Mar 01
11:25am ET
Buy Rating Affirmed for COMPASS Pathways Amid Strategic Advances and Promising Clinical Trials
Mar 01
7:55am ET
Buy Rating on COMPASS Pathways: Overreaction Creates Investment Opportunity Amid Positive Trial Prospects
Feb 29
4:50pm ET
Analysts Offer Insights on Healthcare Companies: GoodRx Holdings (GDRX) and COMPASS Pathways (CMPS)
Feb 29
11:29am ET
Here’s What You Missed in Cannabis, Psychedelics This Week
Feb 29
11:29am ET
Here’s What You Missed in Cannabis, Psychedelics This Week
Feb 29
7:10am ET
Compass Pathways reports Q4 EPS (53c), consensus (33c)
Feb 22
11:19am ET
Here’s What You Missed in Cannabis, Psychedelics This Week
Feb 22
11:19am ET
Here’s What You Missed in Cannabis, Psychedelics This Week
Feb 15
10:57am ET
Rising High: Exclusive talk with cannabis market research firm BDSA
Feb 15
10:57am ET
Rising High: Exclusive talk with cannabis market research firm BDSA
Feb 08
11:22am ET
Rising High: Exclusive talk with house of brands Carma HoldCo
Feb 08
11:22am ET
Rising High: Exclusive talk with house of brands Carma HoldCo
Feb 01
11:35am ET
Rising High: Exclusive talk with drug manufacturer Optimi Health
Feb 01
11:35am ET
Rising High: Exclusive talk with drug manufacturer Optimi Health
Feb 01
11:21am ET
Rising High: Exclusive talk with drug manufacturer Optimi Health
Jan 25
11:09am ET
Here’s What You Missed in Cannabis, Psychedelics This Week
No recent press releases are available for CMPS
CMPS Financials
Key terms
Ad Feedback
CMPS Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
CMPS Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range